Acute lymphoid leukemia.

Definitions in hemophilia. Recommendation of the scientific subcommittee on factor VIII and factor IX of the scientific and standardization committee of the International Society on Thrombosis and Haemostasis. Thromb Haemost (2001) 3.13

Racial differences in the survival of childhood B-precursor acute lymphoblastic leukemia: a Pediatric Oncology Group Study. J Clin Oncol (2000) 2.40

Red cells from glutathione peroxidase-1-deficient mice have nearly normal defenses against exogenous peroxides. Blood (2000) 2.19

Intensive high-dose asparaginase consolidation improves survival for pediatric patients with T cell acute lymphoblastic leukemia and advanced stage lymphoblastic lymphoma: a Pediatric Oncology Group study. Leukemia (1999) 1.89

Intracranial and extracranial hemorrhages in newborns with hemophilia: a review of the literature. J Pediatr Hematol Oncol (1999) 1.88

Preponderance of thiopurine S-methyltransferase deficiency and heterozygosity among patients intolerant to mercaptopurine or azathioprine. J Clin Oncol (2001) 1.82

Chromosomal abnormalities in 478 children with acute myeloid leukemia: clinical characteristics and treatment outcome in a cooperative pediatric oncology group study-POG 8821. Blood (1999) 1.74

The spectrum of Evans' syndrome. Arch Dis Child (1997) 1.69

Levels of p53 protein increase with maturation in human hematopoietic cells. Cancer Res (1991) 1.49

Low or absent SPARC expression in acute myeloid leukemia with MLL rearrangements is associated with sensitivity to growth inhibition by exogenous SPARC protein. Leukemia (2006) 1.42

Home treatment of mild to moderate bleeding episodes using recombinant factor VIIa (Novoseven) in haemophiliacs with inhibitors. Thromb Haemost (1998) 1.35

Factor IX inhibitors and anaphylaxis in hemophilia B. J Pediatr Hematol Oncol (1997) 1.34

Expression of chromosome 21-localized genes in acute myeloid leukemia: differences between Down syndrome and non-Down syndrome blast cells and relationship to in vitro sensitivity to cytosine arabinoside and daunorubicin. Blood (1999) 1.29

Automated dithionite test for rapid, inexpensive detection of hemoglobin S and non-S sickling hemoglobinopathies. Clin Chem (1971) 1.24

Hemoglobin autoxidation and regulation of endogenous H2O2 levels in erythrocytes. Free Radic Biol Med (2005) 1.23

Inhibitors in factor IX deficiency a report of the ISTH-SSC international FIX inhibitor registry (1997-2006). Haemophilia (2009) 1.19

Unresolved issues in diagnosis and management of inherited bleeding disorders in the perinatal period: a White Paper of the Perinatal Task Force of the Medical and Scientific Advisory Council of the National Hemophilia Foundation, USA. Haemophilia (2006) 1.18

Myeloblasts from Down syndrome children with acute myeloid leukemia have increased in vitro sensitivity to cytosine arabinoside and daunorubicin. Leukemia (1997) 1.18

Efficacy of prothrombin-complex concentrates in hemophiliacs with antibodies to factor VIII: a multicenter therapeutic trial. N Engl J Med (1980) 1.16

Reduced folate carrier gene expression in childhood acute lymphoblastic leukemia: relationship to immunophenotype and ploidy. Clin Cancer Res (1998) 1.13

Glucose phosphate isomerase deficiency as a cause of hydrops fetalis. N Engl J Med (1987) 1.11

Anaphylactic response to factor IX replacement therapy in haemophilia B patients: complete gene deletions confer the highest risk. Haemophilia (1999) 1.08

Enhanced metabolism of 1-beta-D-arabinofuranosylcytosine in Down syndrome cells: a contributing factor to the superior event free survival of Down syndrome children with acute myeloid leukemia. Blood (1996) 1.08

Dithionite tube test--a rapid, inexpensive technique for the detection of hemoglobin S and non-S sickling hemoglobin. Clin Chem (1971) 1.08

Comparison of DiOC(6)(3) uptake and annexin V labeling for quantification of apoptosis in leukemia cells and non-malignant T lymphocytes from children. Cytometry (2000) 1.07

Idiopathic thrombocytopenic purpura in childhood. J Pediatr (1966) 1.07

B-domain deleted recombinant factor VIII preparations are bioequivalent to a monoclonal antibody purified plasma-derived factor VIII concentrate: a randomized, three-way crossover study. Haemophilia (2005) 1.07

Prognostic features in acute megakaryoblastic leukemia in children without Down syndrome: a report from the AML02 multicenter trial and the Children's Oncology Group Study POG 9421. Leukemia (2012) 1.03

Low CD4+ counts in a study of transfusion safety. The Transfusion Safety Study Group. N Engl J Med (1993) 1.02

Periodic transfusions for sickle cell anemia and CNS infarction. Am J Dis Child (1979) 1.00

Treatment of familial erythrophagocytic lymphohistiocytosis with cyclosporine A. J Pediatr (1997) 1.00

Phase I trial of paclitaxel in children with refractory solid tumors: a Pediatric Oncology Group Study. J Clin Oncol (1993) 0.99

Development of anaphylactic shock in haemophilia B patients with inhibitors. Blood Coagul Fibrinolysis (1998) 0.98

Oral urea and the prophylactic treatment of sickle cell disease--a preliminary report. Am J Med Sci (1971) 0.98

Variability in serial CD4 counts and relation to progression of HIV-I infection to AIDS in haemophilic patients. Transfusion Safety Study Group. BMJ (1992) 0.98

An increased relative frequency of retinoblastoma at a rural regional referral hospital in Miraj, Maharashtra, India. Cancer (1993) 0.98

Idiopathic thrombocytopenic purpura in children. Semin Thromb Hemost (1977) 0.97

A retrospective study of 69 patients with t(6;9)(p23;q34) AML emphasizes the need for a prospective, multicenter initiative for rare 'poor prognosis' myeloid malignancies. Leukemia (2006) 0.97

Anti-s hemolytic disease: a case report. Transfusion (1967) 0.97

T and B lymphocyte antigen-positive null cell leukemias. Blood (1977) 0.96

Neurological complications of sickle cell anemia. Am J Pediatr Hematol Oncol (1982) 0.96

Elevated dihydrofolate reductase and impaired methotrexate transport as elements in methotrexate resistance in childhood acute lymphoblastic leukemia. Blood (1995) 0.95

DDAVP: does the drug have a direct effect on the vessel wall? Thromb Res (1983) 0.94

The use of porcine factor VIII concentrate (Hyate:C) in the treatment of patients with inhibitor antibodies to factor VIII. A multicenter US experience. Arch Intern Med (1989) 0.94

Oxidant damage to erythrocyte membrane in glucose-6-phosphate dehydrogenase deficiency: correlation with in vivo reduced glutathione concentration and membrane protein oxidation. Blood (1994) 0.94

The incidence of development of irregular red cell antibodies in patients with sickle cell anemia. Transfusion (1986) 0.92

Single nucleotide polymorphisms in the human reduced folate carrier: characterization of a high-frequency G/A variant at position 80 and transport properties of the His(27) and Arg(27) carriers. Clin Cancer Res (2001) 0.91

Congenital transcobalamin II deficiency presenting atypically with a low serum cobalamin level: studies demonstrating the coexistence of a circulating transcobalamin I (R binder) complex. Blood (1984) 0.91

Sickle cell crisis terminated by intravenous urea in sugar solutions--a preliminary report. Am J Med Sci (1971) 0.91

Idiopathic thrombocytopenic purpura in children. The case for management without corticosteroids. Am J Pediatr Hematol Oncol (1984) 0.90

Prognostic factors in children and adolescents with acute myeloid leukemia (excluding children with Down syndrome and acute promyelocytic leukemia): univariate and recursive partitioning analysis of patients treated on Pediatric Oncology Group (POG) Study 8821. Leukemia (2000) 0.89

A prophylactic transfusion program for children with sickle cell anemia complicated by CNS infarction. Am J Hematol (1976) 0.89

Intravenous gamma globulin treatment for chronic idiopathic thrombocytopenic purpura in children. Am J Med (1984) 0.89

Congenital disorders affecting platelets. Semin Thromb Hemost (1977) 0.89

Accumulation of methotrexate polyglutamates, ploidy and trisomies of both chromosomes 4 and 10 in lymphoblasts from children with B-progenitor cell acute lymphoblastic leukemia: a Pediatric Oncology Group Study. Leuk Lymphoma (1998) 0.89

Current practices regarding newborn intracranial haemorrhage and obstetrical care and mode of delivery of pregnant haemophilia carriers: a survey of obstetricians, neonatologists and haematologists in the United States, on behalf of the National Hemophilia Foundation's Medical and Scientific Advisory Council. Haemophilia (1999) 0.88

The overall effectiveness of prophylaxis in severe haemophilia. Haemophilia (2003) 0.86

Identification and characterization of novel AML1-ETO fusion transcripts in pediatric t(8;21) acute myeloid leukemia: a report from the Children's Oncology Group. Oncogene (2008) 0.86

Open heart surgery in a hemophiliac patient. Hematologic management. Am J Dis Child (1974) 0.85

Preoperative exchange transfusion in sickle cell anemia. J Pediatr Surg (1981) 0.85

Hemophilia A in chromosomal female subjects. J Pediatr (1969) 0.85

Cystathionine-beta-synthase cDNA transfection alters the sensitivity and metabolism of 1-beta-D-arabinofuranosylcytosine in CCRF-CEM leukemia cells in vitro and in vivo: a model of leukemia in Down syndrome. Cancer Res (2000) 0.84

Acute lymphoblastic leukemia in a 46,XY/47,XYY mosaic male: clonal origin of leukemia in the XY-bearing stem-cell line. Am J Dis Child (1993) 0.84

Pharmacokinetics of von Willebrand factor and factor VIIIC in patients with severe von Willebrand disease (type 3 VWD): estimation of the rate of factor VIIIC synthesis. Cooperative Study Groups. Br J Haematol (1996) 0.84

Recent evolution of clotting factor concentrates for hemophilia A and B. Transfusion Practices Committee. Transfusion (1993) 0.84

RAS gene mutations in childhood acute myeloid leukemia: a Pediatric Oncology Group study. Genes Chromosomes Cancer (1990) 0.84

Inhibition of CD40 ligand (CD154) in the treatment of factor VIII inhibitors. Haematologica (2000) 0.83

The May-Hegglin anomaly: platelet function, ultrastructure and chromosome studies. Blood (1968) 0.83

Structural physiology of the human spleen. Am J Pediatr Hematol Oncol (1979) 0.83

Leukaemia/lymphoma cell microparticles in childhood mature B cell neoplasms. J Clin Pathol (2004) 0.83

Disseminated intravascular coagulation with trauma: treatment with exchange transfusion. Pediatrics (1979) 0.83

Expression of myeloid-associated and lymphoid-associated cell-surface antigens in acute myeloid leukemia of childhood: a Pediatric Oncology Group study. J Clin Oncol (1992) 0.83

Cytogenetics of juvenile type chronic granulocytic leukemia. Cancer (1977) 0.83

DDAVP: a useful alternative to blood components in moderate hemophilia A and von Willebrand disease. J Pediatr (1983) 0.83

Childhood idiopathic thrombocytopenic purpura. Am J Dis Child (1977) 0.83

Autoplex versus proplex: a controlled, double-blind study of effectiveness in acute hemarthroses in hemophiliacs with inhibitors to factor VIII. Blood (1983) 0.82

Pharmacokinetic interactions of cyclosporine with etoposide and mitoxantrone in children with acute myeloid leukemia. Leukemia (2002) 0.82

Hematological parameters and marrow in vitro colony forming cells in acute lymphoblastic leukemia after cessation of treatment. Nihon Ketsueki Gakkai Zasshi (1980) 0.82

Erythropoiesis in sickle cell anaemia during acute infection and crisis. Scand J Haematol (1979) 0.82

Phenotypic change of acute monocytic leukemia to acute lymphoblastic leukemia on therapy. Am J Pediatr Hematol Oncol (1983) 0.82

Immune status of human immunodeficiency virus seropositive and seronegative hemophiliacs infused for 3.5 years with recombinant factor VIII. The Kogenate Study Group. Blood (1994) 0.81

Desmopressin and thrombosis. Lancet (1989) 0.81

Immune tolerance induction in the treatment of paediatric haemophilia A patients with factor VIII inhibitors. Haemophilia (2000) 0.81

Safety and efficacy of monoclonal antibody purified factor IX concentrate in previously untreated patients with hemophilia B. Thromb Haemost (1996) 0.81

Platelet-vessel-wall interactions: experiences with von Willebrand platelets. Ann N Y Acad Sci (1981) 0.81

HIV and hemophilia. J Thromb Haemost (2007) 0.80

Therapy for childhood acute myeloid leukemia: role of allogeneic bone marrow transplantation. Curr Oncol Rep (2000) 0.80

Characterization of autoantibodies against the platelet glycoprotein antigens IIb/IIIa in childhood idiopathic thrombocytopenia purpura. Am J Hematol (1995) 0.80

Ethanol lock therapy for the treatment of catheter-related infections in haemophilia patients. Haemophilia (2009) 0.80

Chromosomal analysis of metastatic retinoblastoma cells. Humangenetik (1974) 0.80

Erythrocyte age-dependent changes of membrane protein 4.1: studies in transient erythroblastopenia. Pediatr Res (1987) 0.80

Comparison of two schedules of intermediate-dose methotrexate and cytarabine consolidation therapy for childhood B-precursor cell acute lymphoblastic leukemia: a Pediatric Oncology Group study. J Clin Oncol (1994) 0.80

Severe factor VIII and factor IX deficiency in females. Am J Med (1978) 0.79

A pilot study of intermediate-dose methotrexate and cytosine arabinoside, "spread-out" or "up-front," in continuation therapy for childhood non-T, non-B acute lymphoblastic leukemia. A Pediatric Oncology Group study. Cancer (1991) 0.79

Safety and immunogenicity of subcutaneous hepatitis A vaccine in children with haemophilia. Haemophilia (2000) 0.79

Low frequency of meperidine-associated seizures in sickle cell disease. Clin Pediatr (Phila) (1999) 0.79